至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

The CDR1 and Other Regions of Immunoglobulin Light Chains are Hot Spots for Amyloid Aggregation.

Sci Rep. 2019-02; 
Ruiz-ZamoraRobin Axel,GuillauméSimon,Al-HilalyYoussra K,Al-GarawiZahraa,Rodríguez-AlvarezFrancisco Javier,Zavala-PadillaGuadalupe,Pérez-CarreónJulio I,Rodríguez-AmbrizSandra L,HerreraGuillermo A,Becerril-LujánBaltazar,Ochoa-LeyvaAdrián,Melendez-ZajglaJorge,SerpellLouise,Del Pozo-Yauner
Products/Services Used Details Operation
Peptide Synthesis The synthetic peptides used in this study were purchased to GenScript (GenScript Biotech Corp., Piscataway, NJ 08854, USA) ...A complete report of the process of quality evaluation of each peptide was provided to us by the GenScript. Get A Quote

摘要

Immunoglobulin light chain-derived (AL) amyloidosis is a debilitating disease without known cure. Almost nothing is known about the structural factors driving the amyloidogenesis of the light chains. This study aimed to identify the fibrillogenic hotspots of the model protein 6aJL2 and in pursuing this goal, two complementary approaches were applied. One of them was based on several web-based computational tools optimized to predict fibrillogenic/aggregation-prone sequences based on different structural and biophysical properties of the polypeptide chain. Then, the predictions were confirmed with an ad-hoc synthetic peptide library. In the second approach, 6aJL2 protein was proteolyzed with trypsin, and... More

关键词